[HTML][HTML] Fostering healthy aging: the interdependency of infections, immunity and frailty

DL Vetrano, F Triolo, S Maggi, R Malley… - Ageing research …, 2021 - Elsevier
Untangling the interdependency of infections, immunity and frailty may help to clarify their
roles in the maintenance of health in aging individuals, and the recent COVID-19 pandemic …

[HTML][HTML] Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged≥ 65 years: updated …

A Matanock - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
Background Streptococcus pneumoniae (pneumococcus) can cause serious illness,
including sepsis, meningitis, and pneumonia with bacteremia (invasive) or without …

Drivers of and barriers to routine adult vaccination: A systematic literature review

AL Eiden, J Barratt, MK Nyaku - Human Vaccines & …, 2022 - Taylor & Francis
We performed a systematic literature review in PubMed and Embase (2016–2021) to
investigate the drivers of and barriers to routine vaccination in adults aged 50 and older …

[HTML][HTML] Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance …

LL Hammitt, AO Etyang, SC Morpeth, J Ojal, A Mutuku… - The Lancet, 2019 - thelancet.com
Background Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and
14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up …

A global agenda for older adult immunization in the COVID-19 era: a roadmap for action

LA Privor-Dumm, GA Poland, J Barratt, DN Durrheim… - Vaccine, 2021 - Elsevier
Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of
building a global system that can support both routine and pandemic/epidemic adult …

[HTML][HTML] Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects

J Benjamin-Chung, H Li, A Nguyen… - Nature medicine, 2024 - nature.com
Malaria-elimination interventions aim to extinguish hotspots and prevent transmission to
nearby areas. Here, we re-analyzed a cluster-randomized trial of reactive, focal interventions …

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype …

P Izurieta, P Bahety, R Adegbola, C Clarke… - Expert review of …, 2018 - Taylor & Francis
Introduction: Pneumococcal conjugate vaccine (PCV) impact studies have reported
substantial reductions in the incidence of invasive pneumococcal disease (IPD) after …

[HTML][HTML] Changes in serotype prevalence of Streptococcus pneumoniae in Southampton, UK between 2006 and 2018

DW Cleary, J Jones, RA Gladstone, KL Osman… - Scientific Reports, 2022 - nature.com
Streptococcus pneumoniae continues to cause significant disease burden. Whilst
pneumococcal conjugate vaccines (PCV) have substantially reduced this burden, serotype …

[HTML][HTML] The impact of human vaccines on bacterial antimicrobial resistance. A review

KU Jansen, WC Gruber, R Simon, J Wassil… - Environmental …, 2021 - Springer
At present, the dramatic rise in antimicrobial resistance (AMR) among important human
bacterial pathogens is reaching a state of global crisis threatening a return to the pre …

[HTML][HTML] Pneumococcal vaccines: past findings, present work, and future strategies

GS Oliveira, MLS Oliveira, EN Miyaji, TC Rodrigues - Vaccines, 2021 - mdpi.com
The importance of Streptococcus pneumoniae has been well established. These bacteria
can colonize infants and adults without symptoms, but in some cases can spread, invade …